Clinical Trial Reports
CLINICAL TRIAL REPORTS
In an effort to promote accountability and transparency in clinical trial regulation and to build public confidence in our processes, the Authority has begun publishing Clinical Trial Public Assessment Reports (CPARs) and Clinical Trial Public Inspection Reports (CTPIRs) to inform the general public of ongoing clinical trials in Tanzania.
SN | Name | |
---|---|---|
1 | PUBLIC ASSESSMENT REPORT FOR A RANDOMIZED CLINICAL TRIAL OF EARLY EMPIRIC ANTI-MYCOBACTERIUM TUBERCULOSIS THERAPY FOR SEPSIS IN SUB-SAHARAN AFRICA, Version number: CT21 0008 CTPARv2.0 | Download |
2 | PUBLIC ASSESSMENT REPORT FOR THE TRIAL TITLED GENOTYPE-INFORMED VERSUS EMPIRIC MANAGEMENT OF VIREMIA (GIVE MOVE): AN OPEN-LABEL RANDOMISED CLINICAL TRIAL, Version Number: CT20 0003 CPARv2.0 | Download |
3 | PUBLIC ASSESSMENT REPORT FOR GLAUCOMA DETECTION STUDY, KCMC, TANZANIA, Version number: CT21 0013 CPARv2.0 | Download |
4 | PUBLIC ASSESSMENT REPORT FOR MALARIA PF AND MALARIA PF/PAN ANTIGEN RAPID TEST WHO PREQUALIFICATION CLINICAL STUDY, Version number CT21 0006 CTPARv2.0 | Download |
SN | Name | |
---|---|---|
1 | CLINICAL TRIAL PUBLIC INSPECTION REPORT FOR Study Trial and Site: Evaluation of Pharmacokinetics and Safety/Tolerability of Higher Doses of Rifampicin in Children with Newly Diagnosed, Uncomplicated Tuberculosis – KCRI Kilimanjaro | Download |